Loading articles...

Vancouver connection to new COVID-19 vaccine developed by Pfizer

Last Updated Nov 9, 2020 at 9:35 pm PST

FILE - This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. On Monday, Nov. 9, 2020, Pfizer said an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19. (Courtesy of University of Maryland School of Medicine via AP, File)
Summary

Dr. Thomas Madden with Acuitas Therapeutics says since February his team has been working on clinical trials

The medication is 90 per cent effective something Dr. Bonnie Henry is calling promising

While this vaccine could be ready early next year, but it could take several months to make enough to meet demand

VANCOUVER (NEWS 1130) – There’s a Vancouver connection to promising news about a vaccine for COVID-19 developed by Pfizer.

The vaccine is reportedly ninety per cent effective in the latest round of clinical trials.

RELATED: Trudeau says he hopes to see COVID-19 vaccines roll out in Canada in early 2021

Dr. Thomas Madden heads up Acuitas Therapeutics, a biotech firm that ensures the vaccine is effectively delivered and has been working on this since February.

“The early clinical trials were certainly encouraging in that they demonstrated a strong immune response to the vaccine,” he says. “What the current trial has shown is that the immune response is protected.”

Madden says there’s hope this vaccine could be ready early next year, but it could take several months until there can be sufficient supplies manufactured to meet all the demand.

He says while it may take a few months, he’s excited the vaccine could provide some protection against the virus, adding it’s a huge accomplishment for all those involved.

RELATED: Pfizer says early data signals COVID-19 vaccine is effective

“We’re extremely proud. This is a Canadian technology which is playing a critical role so I hope all Canadians recognize they are contributing to the success of this vaccine.”

He adds more staff have been hired in preparation for other companies developing their own vaccines possibly reaching out for support from his team.